HLA-D Antigens

Human immune-response or Class II antigens found mainly, but not exclusively, on B-lymphocytes and produced from genes of the HLA-D locus. They are extremely polymorphic families of glycopeptides, each consisting of two chains, alpha and beta. This group of antigens includes the -DR, -DQ and -DP designations, of which HLA-DR is most studied; some of these glycoproteins are associated with certain diseases, possibly of immune etiology.

Also Known As:

HLA-D; HLA-Dw; Immune Response Associated Antigens, Human; Antigens, HLA D; Antigens, HLA-Dw; Antigens, Human Ia-Like; Antigens, Human Immune-Associated; Antigens, Human Immune-Response; HLA D Antigens; HLA Dw Antigens; Human Ia-Like Antigens; Human Immune-Associated Antigens; Human Immune-Response Antigens; Ia Like Antigens, Human; Immune Associated Antigens, Human; Immune Response Antigens, Human; Antigens, HLA-D; Class II Human Antigens; HLA-Dw Antigens; Human Class II Antigens; Ia-Like Antigens, Human; Immune Response-Associated Antigens, Human; Immune-Associated Antigens, Human; Immune-Response Antigens, Human

Carbohydrates: 22516
- Glycoconjugates: 1370
  - Glycoproteins: 25180
    - Membrane Glycoproteins: 2277
      - Histocompatibility Antigens Class II: 2161
        HLA-D Antigens: 237
Amino Acids, Peptides, and Proteins: 1
- Proteins: 496323
  - Glycoproteins: 25180
    - Membrane Glycoproteins: 2277
      - Histocompatibility Antigens Class II: 2161
        HLA-D Antigens: 237
  - Membrane Proteins: 10262
    - Membrane Glycoproteins: 2277
      - Histocompatibility Antigens Class II: 2161
        HLA-D Antigens: 237
Biological Factors: 2560
- Antigens: 145631
  - Surface Antigens: 5857
    - Histocompatibility Antigens: 1126
      - HLA Antigens: 9074
        HLA-D Antigens: 237
      - Histocompatibility Antigens Class II: 2161
        HLA-D Antigens: 237
  - Isoantigens: 1219
    - Histocompatibility Antigens: 1126
      - HLA Antigens: 9074
        HLA-D Antigens: 237
      - Histocompatibility Antigens Class II: 2161
        HLA-D Antigens: 237

Petra Mrázová Selected Research

Petra Mrázová Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure